SASH1, a new potential link between smoking and atherosclerosis

Atherosclerosis

Volumn 242, Issue 2, 2015, Pages 571-579

  Weidmann, Henri ^a,b,c   Touat Hamici, Zahia ^a   Durand, Herve ^a   Mueller, Christian ^b,c   Chardonnet, Solenne ^a,d   Pionneau, Cedric ^a,d   Charlotte, Frédéric ^e   Janssen, Klaus Peter ^f   Verdugo, Ricardo ^g   Cambien, Francois ^a   Blankenberg, Stefan ^b,c   Tiret, Laurence ^a   Zeller, Tanja ^b,c   Ninio, Ewa ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d INSERM   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF CHILE   (Chile)

Author keywords

Atherosclerosis; CCND1; CCND3; SASH1; Smoking; TP53

Indexed keywords

CYTOCHROME P450 1A1; PROTEIN P53; SASH1 PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; CCND3 PROTEIN, HUMAN; CYCLIN D1; CYCLIN D3; CYP1A1 PROTEIN, HUMAN; SASH1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CAROTID ATHEROSCLEROSIS; CELL FRACTIONATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; TRANSCRIPTOMICS; WOUND HEALING; AORTA; CELL CYCLE; CELL LINE; CELL MOTION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTA; ATHEROSCLEROSIS; CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYCLIN D3; CYTOCHROME P-450 CYP1A1; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING; SMOKING; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84939802809     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.08.013     Document Type: Article

References (49)

1. Libby P., Aikawa M., Jain M.K. Vascular endothelium and atherosclerosis. Handb. Exp. Pharmacol. 2006, 176(Pt 2):285-306.
2. Libby P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32(9):2045-2051.
3. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 2006, 6(7):508-519.
4. Auerbach O., Garfinkel L. Atherosclerosis and aneurysm of aorta in relation to smoking habits and age. Chest 1980, 78(6):805-809.
5. Redgrave J.N.E., Lovett J.K., Rothwell P.M. Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke J. Cereb. Circ. 2010, 41(10):2288-2294.
6. McEvoy J.W., Blaha M.J., DeFilippis A.P., et al. Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the multiethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2015, 35(3):700-709.
7. Talhout R., Schulz T., Florek E., van Benthem J., Wester P., Opperhuizen A. Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health 2011, 8(2):613-628.
8. Varela-Carver A., Parker H., Kleinert C., Rimoldi O. Adverse effects of cigarette smoke and induction of oxidative stress in cardiomyocytes and vascular endothelium. Curr. Pharm. Des. 2010, 16(23):2551-2558.
9. Messner B., Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2014, 34(3):509-515.
10. Zeller T., Wild P., Szymczak S., et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PloS One 2010, 5(5):e10693.
11. Verdugo R.A., Zeller T., Rotival M., et al. Graphical modeling of gene expression in monocytes suggests molecular mechanisms explaining increased atherosclerosis in smokers. PloS One 2013, 8(1):e50888.
12. Zeller C., Hinzmann B., Seitz S., et al. SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is in breast cancer. Oncogene 2003, 22(19):2972-2983.
13. Martini M., Gnann A., Scheikl D., Holzmann B., Janssen K.-P. The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell-matrix adhesion. Int. J. Biochem. Cell Biol. 2011, 43(11):1630-1640.
14. Rimkus C., Martini M., Friederichs J., et al. Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer. Br. J. Cancer 2006, 95(10):1419-1423.
15. Nitsche U., Rosenberg R., Balmert A., et al. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann. Surg. 2012, 256(5):763-771. (discussion 771).
16. Chen E., Chen Y., Dong L., Zhang J. Effects of SASH1 on lung cancer cell proliferation, apoptosis, and invasion in vitro. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 2012, 33(5):1393-1401.
17. Yang L., Liu M., Gu Z., Chen J., Yan Y., Li J. Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 2012, 33(6):2255-2263.
18. Lin S., Zhang J., Xu J., et al. Effects of SASH1 on melanoma cell proliferation and apoptosis in vitro. Mol. Med. Rep. 2012, 6(6):1243-1248.
19. Dauphinee S.M., Clayton A., Hussainkhel A., et al. SASH1 is a scaffold molecule in endothelial TLR4 signaling. J. Immunol. Baltim Md. 1950 2013, 191(2):892-901.
20. Zhou D., Wei Z., Deng S., et al. SASH1 regulates melanocyte transepithelial migration through a novel Gαs-SASH1-IQGAP1-E-Cadherin dependent pathway. Cell Signal 2013, 25(6):1526-1538.
21. Brochériou I., Maouche S., Durand H., et al. Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 2011, 214(2):316-324.
22. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
23. Du P., Kibbe W.A., Lin S.M. Iumi: a pipeline for processing Illumina microarray. Bioinforma. Oxf. Engl. 2008, 24(13):1547-1548.
24. Lin S.M., Du P., Huber W., Kibbe W.A. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 2008, 36(2):e11.
25. Nordskog B.K., Blixt A.D., Morgan W.T., Fields W.R., Hellmann G.M. Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc. Toxicol. 2003, 3(2):101-117.
26. Slattery M.L., Samowtiz W., Ma K., et al. CYP1A1, cigarette smoking, and colon and rectal cancer. Am. J. Epidemiol. 2004, 160(9):842-852.
27. Wierstra I., Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol. Chem. 2007, 388(12):1257-1274.
28. Sitras V., Paulssen R.H., Grønaas H., et al. Differential placental gene expression in severe preeclampsia. Placenta 2009, 30(5):424-433.
29. Bronner I.F., Bochdanovits Z., Rizzu P., et al. Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways. PloS One 2009, 4(8):e6826.
30. Courcet J.-B., Elalaoui S.C., Duplomb L., et al. Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma. Eur. J. Hum. Genet. 2015 Jul, 23(7):957-962.
31. Sakao S., Taraseviciene-Stewart L., Cool C.D., et al. VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2007, 21(13):3640-3652.
32. Beineke P., Fitch K., Tao H., et al. A whole blood gene expression-based signature for smoking status. BMC Med. Genomics 2012, 5:58.
33. Charles P.C., Alder B.D., Hilliard E.G., et al. Tobacco use induces anti-apoptotic, proliferative patterns of gene expression in circulating leukocytes of caucasian males. BMC Med. Genomics 2008, 1(1):38.
34. Sheyu L., Hui L., Junyu Z., et al. Promoter methylation assay of SASH1 gene in breast cancer. J. BUON Off. J. Balk. Union Oncol. 2013, 18(4):891-898.
35. Peng L., Wei H., Liren L. Promoter methylation assay of SASH1 gene in hepatocellular carcinoma. J. BUON Off. J. Balk. Union Oncol. 2014, 19(4):1041-1047.
36. Lee K.W.K., Pausova Z. Cigarette smoking and DNA methylation. Front. Genet. 2013, 4:132.
37. Tsaprouni L.G., Yang T.-P., Bell J., et al. Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation. Epigenetics Off. J. DNA Methylation Soc. 2014, 9(10):1382-1396.
38. Wan J., Johnson M., Schilz J., Djordjevic M.V., Rice J.R., Shields P.G. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 2009, 18(12):3263-3304.
39. Brandon E.F.A., Raap C.D., Meijerman I., Beijnen J.H., Schellens J.H.M. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol. 2003, 189(3):233-246.
40. Fuster J.J., Fernández P., González-Navarro H., Silvestre C., Nabah Y.N.A., Andrés V. Control of cell proliferation in atherosclerosis: insights from animal models and human studies. Cardiovasc. Res. 2010, 86(2):254-264.
41. Moreno P.R., Purushothaman K.-R., Sirol M., Levy A.P., Fuster V. Neovascularization in human atherosclerosis. Circulation 2006, 113(18):2245-2252.
42. Zimmet J.M., Ladd D., Jackson C.W., Stenberg P.E., Ravid K. A role for cyclin D3 in the endomitotic cell cycle. Mol. Cell. Biol. 1997, 17(12):7248-7259.
43. Weng H.-Y., Huang H.-L., Zhao P.-P., Zhou H., Qu L.-H. Translational repression of cyclin D3 by a stable G-Cosponsored in its 5' UTR. RNA Biol. 2012, 9(8):1099-1109.
44. Radulovich N., Pham N.-A., Strumpf D., et al. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Mol. Cancer 2010, 9:24.
45. Barsotti A.M., Prives C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene 2009, 28(48):4295-4305.
46. Wen N., Wang Y., Wen L., et al. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer. J. Transl. Med. 2014, 12:134.
47. Zhao Y.-Y., Gao X.-P., Zhao Y.D., et al. Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. J. Clin. Investig. 2006, 116(9):2333-2343.
48. Wohak L.E., Krais A.M., Kucab J.E., et al. Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism. Arch. Toxicol. November 2014, 10.1007/s00204-014-1409-1.
49. Aviv T., Lin Z., Lau S., Rendl L.M., Sicheri F., Smibert C.A. The RNA-binding SAM domain of smaug defines a new family of post-transcriptional regulators. Nat. Struct. Biol. 2003, 10(8):614-621.